|
|
|
|
LEADER |
01513nam a2200325 u 4500 |
001 |
EB001892068 |
003 |
EBX01000000000000001055215 |
005 |
00000000000000.0 |
007 |
tu||||||||||||||||||||| |
008 |
200301 r ||| eng |
100 |
1 |
|
|a Lachance, Chantelle
|
245 |
0 |
0 |
|a Mindfulness training for chronic non-malignant pain management
|h Elektronische Ressource
|b a review of the clinical effectiveness, cost-effectiveness and guidelines
|c Chantelle C. Lachance, Suzanne McCormack
|
250 |
|
|
|a Version: 1.0
|
260 |
|
|
|a Ottawa (ON)
|b Canadian Agency for Drugs and Technologies in Health
|c June 25, 2019, 2019
|
300 |
|
|
|a 1 PDF file (34 pages)
|
653 |
|
|
|a Canada
|
653 |
|
|
|a Mindfulness
|
653 |
|
|
|a Cost-Benefit Analysis
|
653 |
|
|
|a Chronic Pain / therapy
|
653 |
|
|
|a Treatment Outcome
|
653 |
|
|
|a Pain Management / methods
|
653 |
|
|
|a Practice Guidelines as Topic
|
700 |
1 |
|
|a McCormack, Suzanne
|e [author]
|
710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
490 |
0 |
|
|a CADTH rapid response report: summary with critical appraisal
|
856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK546001
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
082 |
0 |
|
|a 610
|
520 |
|
|
|a The aim of this report is to summarize the evidence regarding both the clinical and costeffectiveness, as well as guidelines for the use of mindfulness training for chronic nonmalignant pain management
|